Literature DB >> 27919115

Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis.

Andreas van Baalen1, Annamaria Vezzani2, Martin Häusler3, Gerhard Kluger4.   

Abstract

Febrile infection-related epilepsy syndrome (FIRES, AERRPS, or DESC) is one of the most severe, mostly irreversible, and presumably immune-mediated epileptic encephalopathies affecting healthy children. Refractory status epilepticus or a cluster of seizures start a few days after the onset of an acute febrile illness; however, encephalitis cannot be proved. Sequelae of FIRES are drug-resistant epilepsy and neuropsychological impairments occurring without latency. Clinical knowledge is limited because FIRES is sporadic and extremely rare. Therefore, based on literature and our data, this review includes clinical features, terminology, epidemiology, diagnostic criteria and procedures, differential diagnoses, acute and chronic therapeutic options, and outcome data. Particular attention is paid to the epileptogenesis. We hypothesize that FIRES is an immune but not an autoimmune disease and discuss GABAergic therapy at high doses, avoidance of burst-suppression coma, and early introduction of enteral or even parenteral ketogenic diet as the most promising treatment. The lack of evidence requires both a network and a multinational web-based clinical registry to define the clinical spectrum for improving diagnosis and treatment and at the very least, to clarify the cause of FIRES. We conclude that the term "fulminant inflammatory response epilepsy syndrome" may be more appropriate. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 27919115     DOI: 10.1055/s-0036-1597271

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  16 in total

1.  Clinical studies and anti-inflammatory mechanisms of treatments.

Authors:  Jacqueline A French; Matthias Koepp; Yvonne Naegelin; Federico Vigevano; Stéphane Auvin; Jong M Rho; Evan Rosenberg; Orrin Devinsky; Peder S Olofsson; Marc A Dichter
Journal:  Epilepsia       Date:  2017-07       Impact factor: 5.864

2.  TMEM16C is involved in thermoregulation and protects rodent pups from febrile seizures.

Authors:  Tongfei A Wang; Chao Chen; Fen Huang; Shengjie Feng; Jason Tien; João M Braz; Allan I Basbaum; Yuh Nung Jan; Lily Yeh Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-18       Impact factor: 12.779

3.  Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study.

Authors:  Jacqueline A French; Andrew J Cole; Edward Faught; William H Theodore; Annamaria Vezzani; Kore Liow; Jonathan J Halford; Robert Armstrong; Jerzy P Szaflarski; Sarah Hubbard; Jagdish Patel; Kun Chen; Wei Feng; Marco Rizzo; Jacob Elkins; Gabrielle Knafler; Kimberly A Parkerson
Journal:  Neurology       Date:  2021-09-14       Impact factor: 9.910

Review 4.  Pharmacotherapy for Pediatric Convulsive Status Epilepticus.

Authors:  Avantika Singh; Coral M Stredny; Tobias Loddenkemper
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

Review 5.  Research progress of vagus nerve stimulation in the treatment of epilepsy.

Authors:  Jing-Jing Fan; Wei Shan; Jian-Ping Wu; Qun Wang
Journal:  CNS Neurosci Ther       Date:  2019-08-19       Impact factor: 5.243

Review 6.  POLG-related disorders and their neurological manifestations.

Authors:  Shamima Rahman; William C Copeland
Journal:  Nat Rev Neurol       Date:  2019-01       Impact factor: 42.937

7.  Hypothesis: Febrile infection-related epilepsy syndrome is a microglial NLRP3 inflammasome/IL-1 axis-driven autoinflammatory syndrome.

Authors:  Wei-Sheng Lin; Ting-Rong Hsu
Journal:  Clin Transl Immunology       Date:  2021-06-14

Review 8.  Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.

Authors:  Gaku Yamanaka; Yu Ishida; Kanako Kanou; Shinji Suzuki; Yusuke Watanabe; Tomoko Takamatsu; Shinichiro Morichi; Soken Go; Shingo Oana; Takashi Yamazaki; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

Review 9.  Management of Autoimmune Status Epilepticus.

Authors:  Batool F Kirmani; Donald Barr; Diana Mungall Robinson; Zachary Pranske; Ekokobe Fonkem; Jared Benge; Jason H Huang; Geoffrey Ling
Journal:  Front Neurol       Date:  2018-05-09       Impact factor: 4.003

10.  A zebrafish-centric approach to antiepileptic drug development.

Authors:  Scott C Baraban
Journal:  Dis Model Mech       Date:  2021-07-07       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.